HEIQ.L

HeiQ Plc
HeiQ PLC - Result of Placing
16th February 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3602D
HeiQ PLC
16 February 2024
 

16 February 2024

 

HeiQ Plc

("HeiQ" or "the Company")

Result of Placing

HeiQ (LSE:HEIQ), a leading company in materials innovation and hygiene technologies, announces that, further to the announcement made on 15 February 2024 regarding the Fundraising (the "Launch Announcement"), it has raised the maximum of £0.685 million (before expenses) via the placing of 7,866,709 Placing Shares at the Issue Price of 8.7 pence per share. The Placing was undertaken through an accelerated bookbuild.

A further announcement will be made on 23 February 2023 announcing the result of the Retail Offer.

A circular will shortly be posted to Shareholders who have opted to receive a hard copy, together with a notice of the General Meeting, to be held at the offices of Cavendish Financial Plc, One Bartholomew Close, London, UK at 2 p.m. on 13 March 2024 (the "Circular"). The Circular will contain further details of the Fundraising, the Acquisition and the General Meeting. This document will also be available to view on the Company's website and on the Financial Conduct Authority's ("FCA") national storage mechanism.

Applications will be made for the New Ordinary Shares and the Conversion Shares to be admitted to the standard segment of the Official List and admitted to trading on the London Stock Exchange ("Admission"). Admission is expected to become effective on or around 14 March 2024 and the New Ordinary Shares and Conversion Shares will be issued fully paid and will rank pari passu in all respects with the existing issued ordinary shares of the Company.

Capitalised terms in this announcement have the same meaning as those defined in the Launch Announcement.

For further information, please contact:

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Cavendish Capital Markets Limited (Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Molly Gretton / Tom Carnegie

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.

Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.

We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.

We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIXELLFZLLLBBB]]>
TwitterFacebookLinkedIn